Amy Wigmore is a partner and a vice chair of the firm's Litigation/Controversy Department, and a member of the Intellectual Property Litigation Practice Group. She joined the firm in 1998. Ms. Wigmore focuses on patent litigation and complex commercial litigation and has represented clients in state and federal courts in several jurisdictions.
Ms. Wigmore has extensive experience representing clients in the pharmaceutical, biotechnology and medical device industries. She has participated in several jury trials, bench trials, and arbitrations involving patent infringement and technology license disputes.
In addition, Ms. Wigmore has represented clients in cases involving the misappropriation of trade secrets, unfair competition, breach of contract, employment disputes, civil rights claims and test security issues. She also has handled congressional investigations and internal corporate investigations.
Ms. Wigmore has significant experience in all facets of the litigation process, including drafting and arguing dispositive motions, managing complex document production efforts, taking and defending depositions, working with experts, examining witnesses at trial, and briefing and arguing appeals.
- Successfully argued on behalf of a pharmaceutical company for dismissal of patent infringement allegations concerning a biotechnology patent on the grounds that the asserted claims were unpatentable.
- Represented a power wheelchair manufacturer in defending against patent infringement allegations in district court and contributed to a successful outcome in Patent Office proceedings in which the asserted claims were found invalid.
- Represented a medical device company in defending a patent infringement case involving surgical ablation devices.
- Successfully argued in the Federal Circuit for dismissal of the appeal of an inter partes reexam in which the patent claims asserted against a medical device manufacturer were found invalid.
- Secured a victory for a pharmaceutical company in a jury trial on patent validity and obtained a $2.15 billion settlement for patent infringement damages resulting from an “at-risk” launch of a generic pharmaceutical product.
- Represented a pharmaceutical company in the appeals of Hatch-Waxman cases involving treatments for Hepatitis C and HIV.
- Represented a major pharmaceutical company in multiple patent cases and US and international arbitrations involving biotechnology patents.
- Successfully represented a pharmaceutical company in a Hatch-Waxman patent infringement case involving a treatment for HIV.
- Served as lead counsel for in a patent infringement case involving biotechnology.
- Served as lead counsel for the defendant in a patent infringement case concerning digital audio technology.
- Represented a medical device company in patent litigation concerning safety needles and blood collection devices.
- Represented a pharmaceutical company in a license dispute concerning drug-eluting stents.
- Successfully represented a pharmaceutical company in a Hatch-Waxman patent infringement case involving a treatment for Parkinson's disease.
- Represented a biotechnology company in a highly successful five-year legal battle involving a licensing dispute with a major clinical diagnostics company. The 10-week jury trial and subsequent appeal led to a $1.4 billion acquisition of our client by the defendant.
Top 250 Women in IP
Life Sciences Star for Intellectual Property
LMG Life Sciences
Leading Lawyer for Intellectual Property Litigation
- Recognized in the 2017-2018 editions of Chambers USA: America's Leading Lawyers for Business for her Washington DC intellectual property litigation practice
- Recommended in the 2016 and 2017 editions of The Legal 500 United States for healthcare: life sciences and intellectual property: patents: prosecution
- Named a Life Sciences Star in the 2016-2017 editions of LMG Life Sciences for intellectual property and named to its 2017 awards shortlist for Hatch-Waxman Litigator of the Year: Branded
- Recognized in 2013-2018 as a leader in her field and an IP Star by Managing IP
- Recognized in 2013, 2014, 2016 and 2018 as among the Top 250 Women in IP by Managing IP
- Recognized in 2010 as one of the World's Leading Life Sciences Patent Litigators in IAM Life Sciences 250, published by Intellectual Asset Management
Insights & News
JD, Harvard Law School, 1995magna cum laude
BA, University of Massachusetts, 1992Phi Beta Kappa
District of Columbia